Literature DB >> 25462211

Is resveratrol a potential substitute for leuprolide acetate in experimental endometriosis?

Yesim Bayoglu Tekin1, Suleyman Guven2, Aynur Kirbas3, Yıldıray Kalkan4, Levent Tumkaya4, Emine Seda Guvendag Guven5.   

Abstract

OBJECTIVE: Resveratrol, a phytoalexin polyphenol, has anti-angiogenic, antioxidant, anti-inflammatory properties. We aimed to compare the anti-inflammatory and anti-angiogenic effects of resveratrol and leuprolide acetate (LA) in an experimental endometriosis model. STUDY
DESIGN: A prospective experimental study was conducted in a University Surgical Research Center. Thirty-three non-pregnant female Sprague-Dawley rats, in which experimental model of endometriosis were surgically induced were randomly divided into four groups. Group 1 was administered 30 mg/kg resveratrol i.m. for 14 days, group 2 was given 1mg/kg s.c. single dose LA, group 3 was administered both resveratrol and LA, and group 4 had no medication. After two weeks medication rats were sacrificed and size, histopathology and immunreactivity to matrix metalloproteinase (mmp)2, mmp9, vascular endothelial growth factor (VEGF) of the endometriotic implants were evaluated. Plasma and peritoneal fluid levels of interleukin (IL)-6, IL-8, and tumor necrosis factor-α (TNF-α) were analyzed.
RESULTS: The endometriotic implant volumes, histopathological grade and immunreactivity to mmp2, mmp9 and VEGF were significantly reduced (p<0.001), and plasma and peritoneal fluid levels of IL-6, IL-8 and TNF-α were significantly decreased in group 1 and group 2 in comparison to group 3 and group 4 (p < 0.001).
CONCLUSION: Resveratrol alone is a potential agent for the treatment of endometriosis and may be an alternative to LA. In contrast, the combination of LA and resveratrol decreased the anti-inflammatory and anti-angiogenic effects of each agent. Since resveratrol is widely used as an alternative therapy for a variety of conditions, it can undermine the effectiveness of LA. Therefore, caution should be exercised when used in combination with other agents.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Endometriosis; Leuprolide acetate; Rat model; Resveratrol; Treatment

Mesh:

Substances:

Year:  2014        PMID: 25462211     DOI: 10.1016/j.ejogrb.2014.10.041

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  12 in total

1.  Therapeutic effects of resveratrol in Escherichia coli-induced rat endometritis model.

Authors:  Murside Ayse Demirel; Sevtap Han; Aytekin Tokmak; Nilufer Ercan Gokay; Mecit Orhan Uludag; Tugçe Yildirir Ustun; Ali Fuat Cicek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-07-31       Impact factor: 3.000

2.  RESVERATROL BINDS NUCLEAR RECEPTOR 4A1 (NR4A1) AND ACTS AS AN NR4A1 ANTAGONIST IN LUNG CANCER CELLS.

Authors:  Lei Zhang; Greg Martin; Kumaravel Mohankumar; Joshua Trae Hampton; Wenshe Rayi Liu; Stephen Safe
Journal:  Mol Pharmacol       Date:  2022-06-09       Impact factor: 4.054

3.  The Effects of Resveratrol Treatment on Bcl-2 and Bax Gene Expression in Endometriotic Compared with Non-Endometriotic Stromal Cells.

Authors:  Roya Kolahdouz-Mohammadi; Ali-Akbar Delbandi; Sepideh Khodaverdi; Soheila Arefi; Tahereh Arablou; Farzad Shidfar
Journal:  Iran J Public Health       Date:  2020-08       Impact factor: 1.429

4.  Euterpe oleracea Extract (Açaí) Is a Promising Novel Pharmacological Therapeutic Treatment for Experimental Endometriosis.

Authors:  Daniel Escorsim Machado; Karina Cristina Rodrigues-Baptista; Jessica Alessandra-Perini; Roberto Soares de Moura; Thiago Alves Dos Santos; Kariny Gomes Pereira; Yasmin Marinho da Silva; Pergentino José Cunha Souza; Luiz Eurico Nasciutti; Jamila Alessandra Perini
Journal:  PLoS One       Date:  2016-11-16       Impact factor: 3.240

Review 5.  Self-management and psychological-sexological interventions in patients with endometriosis: strategies, outcomes, and integration into clinical care.

Authors:  Laura Buggio; Giussy Barbara; Federica Facchin; Maria Pina Frattaruolo; Giorgio Aimi; Nicola Berlanda
Journal:  Int J Womens Health       Date:  2017-05-02

6.  Genistein modulates the estrogen receptor and suppresses angiogenesis and inflammation in the murine model of peritoneal endometriosis.

Authors:  Sutrisno Sutrisno; Hardianti Aprina; Happy Marthalena Simanungkalit; Asti Andriyani; Wisnu Barlianto; Hidayat Sujuti; Sanarto Santoso; Pande Made Dwijayasa; Endang Sri Wahyuni; Edy Mustofa
Journal:  J Tradit Complement Med       Date:  2017-04-25

Review 7.  Anti-Angiogenic Alternative and Complementary Medicines for the Treatment of Endometriosis: A Review of Potential Molecular Mechanisms.

Authors:  Weilin Zheng; Lixing Cao; Zheng Xu; Yuanyuan Ma; Xuefang Liang
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-01       Impact factor: 2.629

Review 8.  Phytoestrogens for the Management of Endometriosis: Findings and Issues.

Authors:  Xia Cai; Min Liu; Bing Zhang; Shao-Jie Zhao; Shi-Wen Jiang
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-14

Review 9.  Endometriosis: current challenges in modeling a multifactorial disease of unknown etiology.

Authors:  Helena Malvezzi; Eliana Blini Marengo; Sérgio Podgaec; Carla de Azevedo Piccinato
Journal:  J Transl Med       Date:  2020-08-12       Impact factor: 5.531

10.  Resveratrol treatment reduces expression of MCP-1, IL-6, IL-8 and RANTES in endometriotic stromal cells.

Authors:  Roya Kolahdouz-Mohammadi; Farzad Shidfar; Sepideh Khodaverdi; Tahereh Arablou; Sahel Heidari; Nesa Rashidi; Ali-Akbar Delbandi
Journal:  J Cell Mol Med       Date:  2020-12-15       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.